Skip to main content
External Relations

Medicine and Dentistry

Our internationally recognised research is rooted in the work we do with communities both locally and globally, transforming lives through innovative, sustainable healthcare solutions. 

Medicine and Dentistry
  1. External Relations
  2. Our support
  3. Content, brand and design
  4. Copywriting toolkit
  5. Key facts and stats
  6. Research and innovation excellence
  7. Medicine and Dentistry

Our excellence by numbers 

  • 7th in the UK for research power for Clinical Medicine (REF 2021).
  • Joint 1st in the UK for research environment for Dentistry (REF 2021).
  • More than 90 per cent of research submissions in Clinical Medicine, Dentistry and Public Health rated as world-leading or internationally excellent (REF 2021).
  • One of seven Faculties to receive the Athena Swan Gold Award in 2023. 

Below are some case studies that exemplify our research excellence. They can be used to give a flavor of the work we do, but by no means cover the full scope of our outputs or impact.

East London Genes and Health

  • East London Genes and Health improves local and global health for 100,000 people of Bangladeshi and Pakistani origin.
  • 60,000 participants so far.  
  • Insights for underserved populations in Low- and Middle-Income Countries.
  • Over £25 million investment from major life sciences companies. 

Find out more about East London Genes and Health.

New life-extending treatment for severe bladder cancer

  • A new life-extending treatment for bladder cancer has been developed by Professor Tom Powles from Queen Mary’s Barts Cancer Institute.
  • The revolutionary combination of chemotherapy with other drugs is the first new treatment for bladder cancer in 40 years.
  • Life expectancy for people with metastatic bladder cancer is just one year, but clinical trials of the new treatment showed patients living up to twice as long.
  • The extraordinary results led to Professor Powles being named as one of the 10 people globally who shaped science by the prestigious journal ‘Nature’.

Find out more about Tom Powles' research.

Elcella

  • Elcella is a natural alternative to weight-loss drugs with zero observed side effects from the use of Elcella over three clinical trials.
  • Our bodies use hormones activated by nutrients to tell our brains when to stop eating. For many overweight and obese people this mechanism doesn’t work as effectively – reducing the ability to feel full and in control of eating.
  • Unlike weight-loss injectables, which use artificial versions of these hormones, Elcella unlocks the power of your own gut to release its own hormone supply, naturally. It is the first and only product to be scientifically proven to do so.
  • Elcella’s scientifically proven approach comes from over ten years of research by gut-health experts Dr Madusha Peiris and Dr Rubina Aktar at Queen Mary University of London – ranked in the top twenty-five globally for research.
  • The anti-obesity market is estimated to be worth $6B a year and expected to grow to up to $100B by 2030, according to Goldman Sachs and Morgan Stanley, with more than a billion people obese.

Find out more about Elcella.

Page last updated on 22/10/25.

Have you spotted an error, or missing information? Please email content@qmul.ac.uk.

Back to top